Fresenius Medical Care

Company snapshot

Fresenius Medical Care is the world’s leading provider of products and services for individuals with renal diseases. We aim to create a future worth living for chronically and critically ill patients – worldwide and every day. Thanks to our decades of experience in dialysis, our innovative research and our value-based care approach, we can help them to enjoy the very best quality of life. Our port

• 1 active pipeline program(s) linked via ClinicalTrials.gov.
• 1 trial update(s) in the last 12 months.

Public regulatory, clinical, patent, and corporate records for Fresenius Medical Care. Not investment advice.

• What is Fresenius Medical Care?

  Vifor Fresenius Medical is a pharma organization headquartered in EU. Primary therapeutic focus areas include Iron Deficiency. NovaPharmaNews links 1 clinical program(s), 0 drug profile(s), and 0 patent record(s) to this entity from public FDA, EMA, ClinicalTrials.gov, and USPTO

• Is Fresenius Medical Care publicly traded?

  Fresenius Medical Care appears in our database through regulatory marketing authorisation or clinical trial sponsor records; a US listed ticker is not shown for this entity.

• What drugs does Fresenius Medical Care develop or market?

  We link 2 drug profile(s) where Fresenius Medical Care is an originator or marketer in FDA or regional approval metadata. See the drug portfolio table on https://novapharmanews.com/companies/vifor-fresenius-medical-care-renal-pharma-france#company-drugs.

• What are the latest developments for Fresenius Medical Care?

  In the last 12 months our linked public records show 1 trial program update(s) and 0 US patent grant(s) tied to this profile.

• What therapeutic areas does Fresenius Medical Care focus on?

  Fresenius Medical Care focuses on Iron Deficiency based on our analysis of their pipeline programs and drug development activities.